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Clinically-available blood pumps and total artificial hearts for pediatric patients continue to
lag well behind those developed for adults. We are developing a hybrid, continuous-flow,
magnetically levitated, pediatric total artificial heart (TAH). The hybrid TAH design
integrates both an axial and centrifugal blood pump within a single, compact housing.
The centrifugal pump rotates around the separate axial pump domain, and both impellers
rotate around a common central axis. Here, we concentrate our development effort on
the centrifugal blood pump by performing computational fluid dynamics (CFD) analysis
of the blood flow through the pump. We also conducted transient CFD analyses
(quasi-steady and transient rotational sliding interfaces) to assess the pump’s dynamic
performance conditions. Through modeling, we estimated the pressure generation,
scalar stress levels, and fluid forces exerted on the magnetically levitated impellers. To
further the development of the centrifugal pump, we also built magnetically-supported
prototypes and tested these in an in vitro hydraulic flow loop and via 4-h blood bag
hemolytic studies (n = 6) using bovine blood. The magnetically levitated centrifugal
prototype delivered 0–6.75 L/min at 0–182 mmHg for 2,750–4,250 RPM. Computations
predicted lower pressure-flow performance results than measured by testing; axial and
radial fluid forces were found to be <3 N, and mechanical power usage was predicted to
be <5 Watts. Blood damage indices (power law weighted exposure time and scalar
stress) were <2%. All data trends followed expectations for the centrifugal pump
design. Six peaks in the pressure rise were observed in the quasi-steady and transient
simulations, correlating to the blade passage frequency of the 6-bladed impeller. The
average N.I.H value (n = 6) was determined to be 0.09 ± 0.02 g/100 L, which is higher
than desired and must be addressed through design improvement. These data serve
as a strong foundation to build upon in the next development phase, whereby we will
integrate the axial flow pump component.
Keywords: pediatric mechanical circulatory support, pediatric total artificial heart, rotary blood pump, rotary blood
pump modeling, pediatric ventricle assist device, pediatric ventricular support
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CLINICAL SIGNIFICANCE AND
MOTIVATION
Globally, more than 17.5 million patients die of cardiovascular
disease, the leading cause of death worldwide (1). Congestive
heart failure (CHF), which is a result of end-stage cardiovascular
disease, affects more than 60 million patients around the world
(2). The clinical need is expected to increase, and the necessity for
effective therapeutic strategies is of critical importance, especially
for infants and children. Millions of pediatric patients around
the world die each year from heart failure due to congenital
or acquired cardiac diseases (3). Complex congenital heart
defects and exposure to viruses and bacteria that attack the
cardiac muscle lead to severely depressed ventricular function
and usually require surgical and therapeutic intervention (4, 5).
Annually, more than 10,000 children in the United States are
hospitalized with CHF-related symptoms, with a mortality rate
of 7–15% (6–8). These pediatric patients often require a heart
transplantation, the current standard of care. Transplantation in
pediatric patients is complicated by challenges in donor-recipient
size matching and anticipated growth potential (9). Despite
∼74% of children being matched and transplanted within 90 days
of listing, the mortality rate range for patients awaiting a donor
organ remains high (5–39%) (7, 10, 11). Thus, this necessitates
the use of alternative therapies, such as mechanical circulatory
support (MCS) devices, including blood pumps.
MCS devices, such as ventricular assist devices (VADs) and
total artificial hearts (TAHs) have been employed to support
pediatric patients with some success (12). The Berlin Heart
EXCOR (Berlin Heart, Berlin Germany) has been employed
for thousands of pediatric patients, and Abbott Laboratories
received U.S. FDA labeling for use of the HeartMate III in older
pediatric patients with advanced refractory left ventricular HF
in December 2020. On a case-by-case basis, blood pumps, such
as the Jarvik Heart (Jarvik Heart Inc., New York, NY) and
HeartMate II axial flow pump, may be employed for pediatric
compassionate use. The SynCardia TAH has 2 sizes (50 and 70
cc) that both have limitations of use in smaller pediatric patients.
Researchers at the Cleveland Clinic have multiple TAHs under
development, including a standard sized device for adults and
adolescents, and a pediatric device, which is 1/3 the total volume
of the adult device.
Development and translation of pediatric MCS devices
continue to lag well behind those developed for adults. To
address the ongoing limitations of existing MCS devices for
pediatric patients, we are developing a hybrid, continuous-flow,
implantable or extracorporeal, magnetically levitated, TAH for
pediatric patients (13, 14). This new device has the capability to be
employed as a right-sided or left-sided VAD, or TAH for partial
or full pediatric cardiovascular support. The hybrid TAH design
integrates both an axial and centrifugal blood pump within a
single, compact housing. Figure 1 displays an illustration of the
clinical implantation of the devices during pediatric MCS of both
the left ventricle (centrifugal blood pump) and the right ventricle
(axial blood pump). The centrifugal pump rotates around the
separate axial pump domain, and both impellers rotate around
a common central axis. In this configuration, the axial flow blood
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FIGURE 1 | Illustration of an implanted Dragon Heart hybrid continuous-flow
blood pump technology. The centrifugal blood pump is designed to support
the systemic circulation and left ventricle, and the axial flow blood pump is
designed to support the pulmonary circulation and right ventricle. In this study,
we focus on the design-build-test of the centrifugal blood pump component of
this device. RA, right atrium; RV, right ventricle; LV, left ventricle; PA, pulmonary
artery.

pump serves to provide MCS to the pulmonary circulation, and
the centrifugal flow blood pump supports blood flow in the
systemic circulation. The internal axial flow pump is designed to
generate 1–6 L/min of flow with a pressure rise range of 10–30
mmHg for the pulmonary circulation, and the outer centrifugal
blood pump is designed to produce 60–140 mmHg for the
systemic circulation at rotational speeds to 10,000 RPM. This
range of pressure generation and flow capacity is required to
support a pediatric cardiovascular load. This constitutes the firstever technology to integrate an axial and centrifugal blood pump
as a TAH. Figure 2 illustrates this design concept, also referred
to as the Drexel Dragon Heart. Since the blood pump domains
are separate, we have to-date concentrated on development
of the centrifugal blood pump, which will contribute most
substantially to the overall size of the device. The centrifugal
flow pump has an inlet volute, exit volute, and magnetically
levitated impeller. The inlet volute supports flow entering the
pump and distributes the flow evenly into the impeller region.
The exit volute directs blood flow out of the pump by slowly
increasing the cross-sectional area to convert fluid velocity to
pressure. The development results presented in this manuscript
reflect the latest design work for the centrifugal blood pump, after
4 design phases.
Here, we performed computational fluid dynamics (CFD)
analysis of the blood flow through the centrifugal pump during
steady and transient conditions. To initiate design of the motor
and magnetic suspension system, we conducted a transient
CFD analysis on the magnetically suspended centrifugal blood
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FIGURE 2 | Hybrid continuous-flow TAH. (1) Upper housing, (2) Centrifugal pump impeller, (3) Axial pump impeller, (4) Lower housing. This configuration consists of
two separate pump domains combined into one pump housing, (5) Concentrated design focus on the centrifugal pump design only: Reduced overall size with an
improved and compact centrifugal impeller and pump design, overall 60 mm in diameter by 50 mm in height, having a radial inlet volute and 37 mm impeller diameter
(6 bladed design).

is the angular speed, D signifies impeller diameter, and µ is fluid
viscosity. Global and local Reynolds numbers were calculated to
above 4,000, leading us to implement a turbulence model. Both
the k-epsilon turbulence and shear stress transport (SST) model
were employed. The shear stress transport (SST) turbulence
model was selected because it combines the robustness of the kε in the bulk flow regime and the k-ω model along the surfaces
or boundaries. A grid independence study was performed to
determine when the grid resolution was no longer affecting the
physics being modeled; we examined parameter values of velocity
(radial and axial) and pressures at more than 10 locations in the
centrifugal pump. Mesh quality was confirmed using standard
mesh metrics, including aspect ratio, Jacobian ratio, skewness and
an ANSYS metric called element quality. All surfaces were set to a
no-slip condition and the simulations were executed using a high
resolution advection scheme. The convergence criterion was set
to a maximum residual threshold below 1 × 10−3 .

pump design to assess its dynamic performance conditions. The
suspension system must compensate for both fluid disturbances
and force perturbations on the levitated rotor-impeller to
consistently maintain its optimally centered position during
operation. Transient simulations are utilized to investigate more
dynamic estimations of fluid disturbances and to quantify the
fluid forces that are required to the design and development the
robust magnetic suspension and motor (15–17). Three types of
simulations were investigated: (1) steady flow simulations using a
frozen-rotor interface specification; (2) quasi-steady simulations
whereby the impeller is rotated manually and a steady state
simulation is performed; (3) transient rotational sliding interfaces
(TRSI), where the rotor-stator domains of the impeller move
in relative motion to each other, simulating blade rotation.
Through computational modeling, we estimated the pressure
generation, scalar stress levels, and fluid forces exerted on the
magnetically levitated impeller. To further the development of
the centrifugal pump, we also built prototypes of the designs and
tested those in an in vitro hydraulic flow loop and by blood bag
hemolytic studies. The findings of these analyses are described in
subsequent sections.

Fluid Physics
Blood is well-known to be a Non-Newtonian fluid (18); it has
been established, however, that a Newtonian fluid assumption
is valid above a threshold strain rate whereby the stress-strain
relationship of blood is primarily linear, indicating Newtonian
behavior (18, 19). For k-epsilon turbulence modeling, we
employed a Newtonian behavior model with a constant viscosity
of 0.0035 Pa∗ s, corresponding to patient hematocrit of ∼33%
(20). In contrast, for the SST turbulence studies, we implemented
a Non-Newtonian model based on a Generalized Oldroyd-B
(GOB) model using relevant coefficients found in literature
(18, 19). This approach utilizes a form of the Naiver-Stokes
where the stress tensor is separated in terms of blood plasma
components (τs ) and red blood cell components (τp ), as shown

MATERIALS AND METHODS
Computational Studies
We employed ANSYS-CFX (ANSYS Inc., Canonsburg, PA) to
simulate both steady and transient blood flow through the
centrifugal pump, and the approach is shown in Figure 3. The
centrifugal pump model (Figure 4A) consisted of several fluid
domains: (1) inlet volute; (2) impeller; (3) outlet volute; and (4)
the secondary flow path. Each of these domains were connected
via fluid-fluid interfaces. We determined the global Reynolds
number using the standard formula for pumps: ρωD2 /µ, where ω
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FIGURE 3 | Computational modeling approach using ANSYS CFX. (1) SolidWorks CAD design of the pump, (2) ANSYS meshing of pump regions, (3) ANSYS
CFX-Pre to define physics and boundary conditions, (4) ANSYS CFX solver to complete the simulation, and (5) ANSYS CFX-post to quantify and visualize the pump
performance metrics (pressure generation, fluid stress levels, velocity profiles). For CFX-post, nodal properties are exported to a Matlab code in order to estimate the
blood damage index for a given operating condition. As an exemplar of the approach, a contour plot of a single bladed centrifugal impeller is illustrated.

reference: frozen rotor and rotor/stator interfaces. In the frozen
rotor mode, the two frames of reference link with a fixed relative
position, but have the correct frame transformation occurring
across the interface. This frame transformation occurs via a patch
mapping technique to interpolate mass flux across interfaces
of varying reference frames (i.e., Frozen Rotor Interface). A
transient rotor/stator simulation, however, involves two or
more domains in relative motion to each other, which more
accurately reflects the physics of a rotating impeller. The
transient rotor/stator interface solution is updated with each
time step as the relative position of the two-grid regions change
with time. The frozen rotor (steady flow) simulation results
were applied as the initial guess for the transient rotor/stator
simulations. The transient interface treatment accounts for
all interaction effects between components in relative motion
to each other, but requires more calculation resources and
time (15–17).

in Equation (1):
ρ


∂ uE
+ ρ uE · ∇ uE = −∇p + ∇ · τs + τp
∂t

(1)

where ρ signifies the fluid density, p represents the pressure, and
uE is the fluid velocity vector.
The red blood cell stress tensor component includes a
dissipative term using the Oldroyd derivative (τ ’p ), which relates
the red blood cells stresses to the rate of change of the stress. In
the model developed by Good et al. (18), a parameter limited
term with constant α = 0.5 was included to mathematically
bound the predicted stress. The coefficients of this model were
experimentally derived using pediatric blood, including two
coefficients (η, η1 ) bounding the viscosities as the shear rates
approach zero and infinity. The elastic shear modulus (µ) was
determined by finding a least squares fit of experimental data.
In this study, we utilized this model and selected the closest
hematocrit option of 40% and therefore the η, η1 , and µ were
defined as 31.1, 8.9, and 53, respectively (19). We specified a fluid
density of 1,050 kg/m3 for these simulations.

Boundary Conditions
Non-uniform Inflow Velocity

Modeling Reference Frames

To simulate fully developed inlet flow, a non-uniform inflow
velocity profile was implemented as the inlet boundary condition
to the centrifugal blood pump. Equation (2) details the expression
that was defined for the inlet velocity profile with a power variable
(β) equal to 1/7 for turbulent inflow conditions. The radius of
inflow boundary of the inlet volute is specified as Rmax (4 mm),
and a maximum fluid velocity (umax ) is defined to achieve the

Two reference frames (rotating and stationary domains) were
established in these simulations. The impeller domain was
specified to be in the rotating reference frame. The inlet volute,
outlet volute and secondary flow path were assigned to the
stationary reference frame. ANSYS CFX provides two main
options to define the interfaces between two differing frames of
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FIGURE 4 | Computational modeling: (A) Model with regions labeled, (B) Pressure-flow performance curves for operating conditions of 3,000 to 4,000 RPM at flow
rates of 1 to 6 L/min for the SST turbulence model, (C) Comparison of pressure-flow performance curves for the SST and k-epsilon turbulence models for operating
conditions of 3,000 to 4,000 RPM at flow rates of 1 to 5 L/min, (D) Qualitative comparison of experimental hydraulic data for the 3,500 RPM operating speed with the
computational predictions of the k-epsilon and SST turbulence models, (E) Pressure rise across the centrifugal pump using a quasi-steady analysis, (F) Pressure rise
across the centrifugal pump using TRSI analysis.

rotational position (i.e., 60 models at 6◦ impeller rotations to
achieve a 360◦ full rotation). The inlet boundary condition was
specified as a non-uniform velocity profile (umax of 0.75 m/s; β of
1/7), and the outlet boundary condition was defined as a constant,
static pressure afterload (200 mmHg). We ran 60 simulations to
derive the full 360◦ time-averaged performance profile for the
centrifugal pump at 3,500 RPM (15–17).

target flow rates of ∼1–5 L/min (0.25–1.55 m/s).

u(r) = umax 1 −

r
Rmax

β

(2)

Frozen Rotor Steady Flow Simulations
Flow through the centrifugal pump was initially modeled as
steady state. The impeller rotor was specified as rotating in
the counterclockwise direction in accordance with the blade
orientation, and the impeller hub, in the secondary flow path
domain, was specified as a rotating surface. The frozen rotor
interface linked regions of differing reference frames. The nonuniform mass inflow rate and operational rotational speed were
specified for each steady-flow simulation. The outflow pressure
was set to be a constant, static pressure afterload (200 mmHg).
Both the k-epsilon turbulence and the shear stress transport
(SST) model were specified, and rotational speeds of 3,000, 3,500,
and 4,000 RPM were modeled for flow rates of 1-6 L/min, set by
establishing the maximum velocity value, umax (0.25–1.55 m/s),
in Equation (2).

Transient Rotational Sliding Interfaces (TRSI) Simulations
The TRSI simulations involved the application of a non-uniform
inflow velocity profile (umax of 0.75 m/s; β of 1/7) and a rotational
speed of 3,500 RPM according to the pump design point. The
outflow boundary condition or aortic mean pressure (AOP) was
set to a constant physiologic value. We employed the rotorstator interface, rather than the frozen-rotor, for the regions
of differing reference frames. The rotor-stator interface more
accurately models the motion of the rotating impeller relative to
the stationary pump internal housing. Since the rotational speed
is relatively high in each case, this simulation requires a small
time step to resolve the transient fluid dynamics and capture
the impact of the blade passage frequency (BPF). Rotational
increments of 4.725◦ , corresponding to a time step of 2.225 ×
10−4 s, were implemented for 3,500 RPM. This set of simulations
included two full revolutions of the impeller (720◦ ) (15–17).

Quasi-Steady Flow Simulations
The purpose of the quasi-steady study was to assess the impact
of centrifugal impeller blade rotational position on pump
performance and fluid dynamics. We incrementally rotated the
impeller blades by 6◦ and created a new, separate model for each
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Scalar Fluid Stress Analysis
High operating rotational speeds and narrow (blade tip)
clearances between the rotating and stationary regions of the
centrifugal pump may produce unacceptable shear stresses and
result in damage to red blood cells. This blood trauma may, in
turn, activate platelets and trigger clot initiation downstream,
contributing to potential thromboemboli. Irregular flow patterns
also contribute to the risk of hemolysis and thrombosis by
increasing levels of fluid stresses. Thus, scalar stress values
were numerically estimated during these simulations along with
corresponding blood damage indices. An estimation of the scalar
fluid stress levels in blood pumps was proposed by Bludszweit
et al. (21, 22). This approach leverages comparative stress theory
to produce a mathematical expression for fluid stresses based on
the von Mises yield criterion of solid mechanics theory. Equation
(3) was used in this study to calculate the scalar stress (σ), which
includes the components of the stress tensor and represents the
level of stress experienced by the blood:

σ =

 X

2 X 2 1/2
1
σii − σjj +
σij
6

(3)
FIGURE 5 | Design Progression of Magnetically Levitated Centrifugal Pump
Prototypes. (A) Initial polylactic acid (PLA) extruded pro-totypes, (B)
Stereolithographic 3D printing prototypes machined for testing, (C) Final pump
prototype with point and support stabilization, (D) Top inlet volute with fluid
seal in place and magnetic drive components to support impeller.

We also examined fluid streamlines as indicators of numerically
predicted fluid residence times. A power law relationship
according to Equation (4) was utilized to relate the scalar stresses
and residence time in the estimation of a blood damage index:

D=

Outlet
X

1.8x10−6 ∗ σ 1.991 ∗ 1t 0.765

adapted to encapsulate the magnets inside of the pump
housing. The prototypes were then fitted with fluid seals
and tested in existing hydraulic and hemolytic test loops
to characterize the pressure-flow pump performance and
hemolytic potential.

(4)

Inlet

where “Inlet” and “Outlet” represent the inflow and outflow faces
of the pump domain and the fluid inlet region to the bundle, D is
the damage index, σ signifies the scalar stress and t is the exposure
time (23). This provides a statistical estimation of the probability
for blood damage to occur from the inlet to the outlet of the
centrifugal pump. Using this power law relationship between the
scalar stress level and the exposure time, a blood damage index
was estimated (23). We assess a maximum scalar stress value of
425 Pa and a maximum residence time of 600 ms as our design
threshold (24, 25). In this analysis, we track the stress history of
the fluid via particle streamlines. The accumulation of stress and
exposure time was discretely summed along the streamlines to
evaluate the potential for blood damage. This approach provides
a statistical estimate of damage to blood cells traveling through
this blood pump using a power law equation, as described in
(13, 14).

Hydraulic Testing
The centrifugal prototype was hydraulically evaluated utilizing
a blood analog solution composed of water and glycerol
(standard 60/40% v/v). Figures 6A–K illustrates the test rig
configuration and pump prototype. This analog fluid was
calibrated to have a measured viscosity and density of
∼0.00353 Pa∗ s and 1,054 kg/m3 , respectively. After filling
the hydraulic test-rig, we removed entrained air bubbles. The
test loop consisted of two reservoir tanks (inlet and outlet
tank) with the pump located between them and a tubing
clamp to adjust resistance and therefore flow in the circuit.
Each tank was connected to a differential pressure transducer
(Validyne, Northridge, CA, USA) to measure the pressure rise
across the pump prototypes. Flow was measured using an
external flow sensor (Transonic, Ithaca, NY, USA). A BLDC
motor and controller (Faulhaber GmbH, Schonaich, Germany)
was used in conjunction with the integrated magnets to
induce impeller rotation (13). We collected flow rates and
pressure measurements at rotational speeds from 2,750 to
4,250 RPM in 250 RPM intervals. Data were collected using
a data acquisition (DAQ) board (LabJack Corp., Lakewood,
CO, USA).

Prototype Manufacturing
After modeling, the centrifugal impeller and volutes
were prototyped from watershed resin material using
stereolithographic techniques (Figure 5). The centrifugal
impeller, made by rapid prototyping, was attached to
a set of diametrically polarized magnets, designed and
manufactured by our team. The lower housing of the centrifugal
pump, containing both the outlet and outlet volute, was
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FIGURE 6 | Hydraulic Test Rig, Centrifugal Prototype, and Performance Results: (A) Magnetically Levitated Drive System, (B) centrifugal blood pump, (C) Validyne
differential pressure transducer, (D) Transonic Ultrasonic flow probe, (E) Inlet tank, (F) Outlet tank, (G) Air bleed hoses, (H) Inlet volute, (I) Outlet volute, (J) Impeller, (K)
Partially assembled prototype, (L) Prototype Performance Results: 0-6.7 L/min at 0.5-180.3 mmHg for 2,750-4,250 RPM.

Hemolytic Experiments
Figure 7 illustrates the experimental configuration for the in vitro
hemolysis testing. The experiments were completed using bovine
blood, selected in accordance with ASTM 1830-97 (Standard
Practice for Selection of Blood for in vitro Evaluation of Blood
Pumps). The accumulated levels of plasma free hemoglobin
(pfHb) were measured hourly for 4-h using the optical Cripps
method (26) to characterize the degree of hemolysis for the
centrifugal prototype. Experiments (n = 6) were performed
according to our lab protocol, which follows ASTM 1841-97
(Standard Practice for Assessment of Hemolysis in Continuous
Flow Blood Pumps). The flow loop was partially submerged
in a 37◦ C water bath, controlled with a thermocouple and
heating element, to maintain the temperature of the blood at
or near 37◦ C for the duration of the experiment. Prior to
filling, the flow loop was filled with phosphate buffered saline
(PBS) solution to wet the internal surfaces of the loop. The
bovine blood (Lampire Laboratories, Pipersville, PA, USA) was
collected via venipuncture and shipped in a standard 1,000
mL bags containing citrate phosphate dextrose adenine (CDPA)
anticoagulant. The blood bags were slowly warmed to 37◦ C in a
water bath prior to the experiment.
After quickly draining the PBS solution, blood was introduced
into the loop through a 150-micron filter. Once full, a blood
sample was collected for the baseline measurement (initial
condition, time = 0). The pump was started and slowly brought
to operational rotational speed over 15 min, yielding a flow of
about 2 L/min. At each 30-min interval, ∼2–4 mL of blood
aliquot was collected from the inlet tank. Two capillary tubes
were filled using this sample and then placed into a centrifuge
(Hettich Haematokrit 210 centrifuge, Oxford, CT). After rotation
(8 min at 8,000 RPM), visual inspection using the 210 centrifuge
tool itself enabled us to measure the hematocrit. Measurements
were taken twice in parallel and averaged.
The remaining blood was then transferred to Covidien
EDTA blood collection tubes and centrifuged for 8 min at 4,000

Frontiers in Cardiovascular Medicine | www.frontiersin.org

FIGURE 7 | Magnetically Levitated Centrifugal Pump for Hemolysis Testing:
(A) Centrifugal Pump (Inlet Volute, Outlet Volute, Fluid Seal, Magnetic Drive
Impeller and Ceramic Thrust Bearings), (B) Brushless DC Motor, (C) No
Contact Diametrically Magnetized Cup Magnet, (D) Flow Sensor, (E) Heat
Bath Circulation Pumps, (F) Waterproof Thermocouple, (G) Cooling Fan, (H)
Heater, (I) Heath Bath Partition, (J) Heparin Coated Tubing, (K) Leur-Lok Fill
and Draw Ports, (L) Commercial blood bag as supply reservoir, (M)
Connected set-up, (N) Pump placement and filled test rig.

RPM to separate the plasma layer from the packed red cells.
Using a transfer pipette, the plasma layer was collected for
spectrophotometric analysis. The optical density or absorbance
was measured at 576.5 nm, 560 nm, and 593 nm, using a Genesys
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determined using a grid independence study to determine when
the grid resolution was no longer affected the physics being
modeled (<3% variable variance). All mesh elements were
required to have an aspect ratio <100, Jacobian ratio <40, a
skewness <0.25 and an element quality measure >0.75; these
were achieved for all model constructs. The k-epsilon model
satisfied the y+ mesh requirement of being >11 along all walls
and surfaces. Inflation layers were also used to achieve the
SST turbulence model requirement (y+ <2). This mesh-build
analysis indicated that ∼3 million elements was sufficient to
achieve grid independence.

10Vis spectrophotometer (ThermoFisher Scientific, Waltham,
MA). We determined the pfHb based on the weighted difference
in absorbance measurements, according to the Cripps method in
Equation (4) (26):


pfHb(mg/dL) = 177.6 × A1 − (A2 + A3 )/2

(5)

where A1 corresponds to the absorbance at wavelength (λ1 ) of
576.5 nm, A2 reflects the absorbance at wavelength (λ2 ) of 560.0
nm, and A3 is the absorbance wavelength (λ3 ) of 593.0 nm. The
normalized index of hemolysis (N.I.H) was calculated using the
following standard relationship in Equation (5):
N.I.H(g/100L) = V ∗ 1pfHb ∗

(100 − Hct)
100
∗
100
1t ∗ Q

Steady Flow Simulation Findings
Over 400 simulations were performed on the centrifugal pump
using the model in Figure 4A. Figures 4B,C illustrate the
pressure-flow performance for this pump design over a range of
flow rates and rotational speeds for both the SST and k-epsilon
turbulence models. Each data point corresponds to a steady state
simulation for a specific flow rate and rotational speed. The
pressure rise across the centrifugal pump design was determined
for flow rates of 0.5 to 6 L/min for 2,750 to 4,250 RPM. A pressure
rise of 10 to 145 mmHg was achieved over these operating
conditions (Figure 4B). The design point of 3 L/min at 3,500
RPM demonstrated a pressure rise of ∼95 mmHg. Pressure rise
was found to decrease with increasing flow rate and was higher
at faster rotational speeds. This trend, as expected, was observed
for both turbulence models. The pressure performance curves
demonstrate the pump’s ability to deliver an adequate flow range
with target pressure rises at reasonable rotational speeds. For flow
rates <3 L/min, the calculated expected pressure rises for the two
turbulence models were observed to be 12–23% mmHg different
in magnitude. At flow rates >3 L/min, the pressure rises were
within 4–8% of each other, as seen in Figure 4C.
Axial fluid forces exerted on the magnetically levitated
impeller rotor surface ranged from 0.4 to 2.5 N, and the radial
fluid forces were found to be much lower in magnitude, ranging
from 0.17 N to 0.84 N. As expected, higher axial fluid forces
were observed for operating conditions yielding higher pressure
generations. Hydraulic efficiencies (10–28%) were determined
using the computational torque, enabling an estimation of the
mechanical power usage, which ranged from 0.79 Watts to
4.58 Watts.
Fluid velocities were inspected in all models and at
all operating conditions. Figure 8 displays the fluid velocity
vectors for the centrifugal pump model at the design point.
Highlighted regions include the cutwater at the outlet of the
pump, impeller tip clearance, and secondary flow path. These
regions demonstrated irregular, vortical flow conditions, per the
computational predictions. Outside of these regions, blood flow
transitioned well from region to region across the centrifugal
blood pump.
Tables 1, 2 indicate the scalar stress estimations and blood
damage index calculations. All operating conditions resulted in
blood damage indices of <2%, the threshold level for our designs.
Approximately 99% of the computational walls and surfaces
had scalar stresses below 425 Pascals. The fluid residence times,
measured via streamlines, were all <600 ms, meeting the target

(6)

where V ∗1pfHb signifies the increase in plasma free hemoglobin
(g/L) over the sampling time interval, Hct is the blood hematocrit
(%), 1t corresponds to the sampling time in minutes, Q
represents the flow rate in liters per minute, and V is the
circulating volume of the hydraulic loop in liters.

Data Analysis
Simulation results were assessed qualitatively and quantitively.
We estimated the pressure generation, scalar stress levels, and
fluid forces exerted on the magnetically levitated impeller. For
the transient runs, data analysis was performed on the second
revolution results for each case. To quantitatively compare the
pressure-flow performance of the models with the prototype
performance, we used a regression analysis that is detailed in
(27). This approach involves the calculation of non-dimensional
pressure and flow coefficients for the data sets. The regression
model includes characteristic constants (β0 , β1 , β2 ), as described
in this equation:

ψTYPE = β2 ϕTYPE 2 + β1 (ϕTYPE ) + β0

(7)

The subscript “Type” is generic since comparisons were made
across data sets of computational predictions and experiments.
The F-test for the regression analysis was used to assess the
significance of the coefficients and polynomial models based
on the data normality. We then determined an average and
maximum deviation between data sets.
The hemolytic data were analyzed according to standard
ANOVA principles using SPSS. A Shapiro-Wilk normality test
was completed in conjunction with a Tukey-Hoaglin outlier test.
A test of homogeneity of variance was conducted to analyze
the variance between the six different experimental results
for N.I.H. values, and heteroskedasticity test was utilized to
assess significance of time point values across experiments. All
statistical analyses were based on a preset α value of 0.05.

COMPUTATIONAL RESULTS
Mesh Quality
The mesh for all fluid domains was created using the mesh
generator within ANSYS, and the required mesh density was
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FIGURE 8 | Velocity Vectors for the Centrifugal Pump Model at 3,500 RPM and 3 L/min. (A) Cutwater Region, (B) Impeller Blade Tip, (C) Secondary Flow Path and
Impeller Cutwater Region at the Outlet Volute. These are midspan views across the centrifugal blood pump. The central midspan is indicated at 0 mm, and two
additional midspan views are shown 1 mm above and -1 mm below the central midspan.

TABLE 2 | Fluid stress level and blood damage index estimations for the
centrifugal pump model.

TABLE 1 | Fluid stress level and blood damage index estimations for the
centrifugal pump model.
Flow rate
(L/min)

Scalar stress (Pa)
Avg

% > 425

Damage index (%)
Mean

Max

Scalar stress (Pa)
RPM

Operating rotational speed of 4,250 RPM

Avg

Damage index (%)

% > 425

Mean

Max

Operating flow rate of 3 L/min

3

59.9

0.7

0.170

1.12

4,250

59.9

0.7

0.170

1.12

4

66.6

1.0

0.193

1.06

4,000

53.6

0.4

0.141

0.81

5

66.5

1.0

0.178

0.80

3,750

47.7

0.2

0.129

0.15

3,500

42.0

0.1

0.083

0.66

Flow rate

Scalar stress (Pa)

Damage index (%)
Rotational Speeds of 3,500–4,250 RPM at 3 L/min.

(L/min)

Avg

% > 425

Mean

Max

Operating rotational speed of 3,500 RPM
3

42.0

0.08

0.083

0.66

4

50.2

0.27

0.099

0.53

5

54.0

0.55

0.098

0.58

rotational increments of 6◦ . This study was performed at
3,500 RPM and 3 L/min. Six peak pressure generations were
observed, and these peak pressure generations occurred at
every 60◦ . The peaks correlate with blade number, and a
shift in the pressure rise was observed from 86 to 95 mmHg,
indicating a blade passage influence in the pressure rise across
the pump.

Flow rates of 3–5 L/min at Rotational Speeds of 3,500 RPM and 4,250 RPM.

requirement. As expected, higher rotational speeds yielded higher
scalar stress levels. Higher scalar stresses were found in the blade
tip clearances, at the leading edge of the blades, near the cutwater
region in the outlet volute, and on the suction side (i.e., backside)
of the impeller blades.

TRSI Results
Figure 4F demonstrates the TRSI simulations for a rotational
speed of 3,500 RPM at 3 L/min. The average pressure
generation was found to range from 74 to 96 mmHg,
which is a much wider range than indicated by the quasisteady study. Pressure fluctuations due to the blade passage
frequency are more significant and can be observed with the
expected 6 peaks in a full rotation. The axial and radial
fluid forces ranged from 1.71 to 1.93 N, and 0.16 to 0.79 N,
respectively.

Transient Flow Simulation Findings
Quasi-Steady Study on the Centrifugal Impeller
Figure 4E illustrates the computational predictions for the quasisteady analysis of the centrifugal blood pump and the impact
on pressure generation as a function of rotational position
of the impeller blades. Sixty simulations were completed for
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TABLE 3 | Normalized Index of Hemolysis (N.I.H) for bovine blood studies.

DISCUSSION

Experiment

To provide a new therapeutic solution for pediatric patients with
heart failure, we are developing a new blood pump technology
in the form of a continuous-flow, magnetically levitated TAH
(13, 14). The overall target size of this TAH is 50 mm in diameter
by 50 mm in height and has only 2 moving parts, an axial
and centrifugal impeller, each levitated by magnetic suspension.
Thus, this blood pump technology is expected to be able to
provide extracorporeal MCS to patients <0.65 m2 (i.e., <12 kg or
younger than ∼2 years old) and intracorporeal MCS to patients
>0.65 m2 (i.e., >15 kg or older than ∼2 years old). The axial
pump mechanically supports the pulmonary circulation, and the
centrifugal impeller supports the systemic circulation. The device
utilizes the latest generation of magnetic bearing technology
to levitate the impellers, enabling a longer operational lifespan
and wider clearances between the rotating impeller surfaces and
pump housing (about 5× wider than mechanical bearings). These
wider clearances reduce fluid shear stresses and lower the risk of
thrombosis and hemolysis. This design also avoids the use of the
mechanical or biologic valves that can fail prematurely.
Initial designs have been developed for both the axial and
centrifugal pumps (13, 14). Since the axial region and centrifugal
fluid domains are separate and independent from each other, the
pumps can initially be developed separately. The data presented
in this paper, consisting of both computational and experimental
studies, has concentrated on the design and development of the
centrifugal pump and presents the latest developmental progress.
In the computational studies, two turbulence models were
employed: k-epsilon and SST models. A quantitative comparison
of the computational predictions, using both turbulence models,
and the experimental measurements of the centrifugal pump
prototype was performed. Figure 4D illustrates this comparison.
For flow rates <3 L/min, the SST model correlated to within
10% of the experimental measurements, and the k-epsilon model
correlated to within 19% of the experimental measurements.
The SST and k-epsilon models correlated to within 5–8% of
the experimental measurements for flow rates >3 L/min. The
SST turbulence model utilizes a blending function to transition
between near-wall modeling equations and bulk k-epsilon
modeling equations. It is expected that as the flow rate increases,
yielding higher Reynolds numbers, the SST and k-epsilon
models would predict more similar results. This was observed
computationally. Deviations between CFD and experiments are
expected. While the choice of turbulence model is important to
the accuracy of the simulations, there is no definitive approach
to determine which turbulence model is optimally suited for
miniature blood pumps; where the blood flow conditions are
highly dynamic and likely fluctuate among laminar, unsteady
transitional, and truly turbulent flow conditions.
The only rotating component in the centrifugal pump is
the impeller and its 6-bladed impeller that causes the observed
blade passage frequency in the fluid physics. This effect was
observed using both quasi-steady analysis and the transient
TRSI approach. Six peak pressure rises, corresponding to the six
blades, were observed in the computational data sets. Pressure
fluctuations due to the blade passage frequency were more

N.I.H (g/100 L)

N=1

0.10

N=2

0.10

N=3

0.12

N=4

0.11

N=5

0.07

N=6
Ave

0.06
0.09 ± 0.02*

Repeated (n = 6) hemolytic studies at ∼2 L/min using magnetically levitated centrifugal
pump prototype. *p < 0.05.

Hydraulic Results
Figure 6L displays the pressure-flow hydraulic performance
results for the testing speeds of 2,750–4,250 RPM in 250
RPM intervals. The magnetically levitated centrifugal prototype
delivered 0–6.75 L/min at 0–182 mmHg over those rotational
speeds. Higher rotational speeds led to more substantial pressure
rises at a given rotational speed. Moreover, higher flow rates
produced lower pressure rises at a given rotational speed.
These trends met expectations for centrifugal pumps. The
full flow range of testing for 2 rotational speeds were remeasured, and the pressure-flow performance data demonstrated
repeatability.

Hemolytic Results
Over each 4-h hemolytic test period, the rotational speed,
temperature and flow rate were held constant, and we drew
test samples every 30 min. The bovine blood in the circuit
was maintained at a temperature of 36.31 ± 1.94◦ C, a flow
rate of 2.06 ± 0.06 L/min and rotational speed of 1,080 ±
228 RPM. The initial bovine blood hematocrit values ranged
between 30 and 38% and slightly decrease over the duration
of the study; an average hematocrit drop of 1.8% ± 0.7%
(p < 0.5) was measured for all experiments. The pfHb
levels increased linearly over the experiment 4-hr duration,
as expected. The Shapiro–Wilk test supported a normality
assumption (p > 0.05), and the pfHb concentration linearity
was verified via regression statistics using F-test and coefficient
t-test (p < 0.5). The significance and independence of each
hourly average pfHb level was also assessed. No outliers were
determined per the Tukey-Hoaglin outlier test. A test of
homogeneity of variance was showed that there was equal
variance between experimental data sets (p > 0.5). An Ftest for heteroskedasticity demonstrated that the variance of
the errors does not depend on time, thus further supporting
the significance and independence of each hourly average
pfHb measurement. Table 3 shows the N.I.H determinations
for each experiment, which ranged from 0.06 g/100 L to
0.12 g/100L. The average N.I.H value (n = 6) for all of
the experiments was determined to be 0.09 ± 0.02 g/100 L
(p < 0.05).
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being designed using 3-D MRI images of human thoracic
cavities. Moreover, we have constructed a lumped parameter
model of the cardiovascular system such that we can include
downstream and upstream boundary conditions in a multi-scale
computational platform. The balance of blood flow and preload
distribution between the pulmonary and systemic circulations is
also an ongoing challenge for continuous flow TAHs, especially
for those that utilize a single-rotor configuration. In this
configuration, the axial and centrifugal pumps are separate
and thus can be controlled independently; nevertheless, we
must determine optimal control algorithms during the next
development phase. Fit and placement will also be virtually
examined, and control algorithms will be devised to ensure either
RPM for pulsatility in the outflow for long-term mechanical
circulatory assistance or to maintain continuous flow during
acute support scenarios. A focus is also currently on the
motor and magnetic suspension system integration and a size
reduction in preparation for acute animal experiments during
next steps.

pronounced for the TRSI simulations, and axial and radial
fluid force ranges were wider for the TRSI study. Nevertheless,
significant pressure and fluid force deviations between the quasisteady and TRSI simulations were not found, in accordance with
prior studies (16).
Per the hydraulic studies, the centrifugal pump prototype
delivered target pressure rises and capacities to support pediatric
patients. We chose the tightest tolerancing for prototype
manufacturing (Applied Rapid Technologies, Fredericksburg,
Virginia, USA) in support of the impeller geometry, blade tip
clearance and secondary flow path dimensions. Trends among
performance of the computational models and prototypes were
similar for the centrifugal model and prototype testing; both
data sets followed expected trends according to pump design
theory (28). Computations predicted the axial fluid forces to be
<3 N and radial forces of <1 N for the centrifugal pumps; these
forces correlate well with levels of other magnetically-levitated
centrifugal blood pumps. The higher scalar stress along the blade
tips, leading edge of the impeller blades, and at the cutwater
region is also to be expected due to the presence of transitional
velocity gradients and proximity of rotating-stationary surfaces.
After completing this study, we explored improving the mesh
element in these regions and found that the scalar stress is highly
sensitive to the volume skew of the elements in these regions.
A recent publication also indicates shear stresses being sensitive
to mesh characteristics (29). The majority of scalar stress values
were below 425 Pascals, and blood damage indices were below the
design criteria of 2% for all operating conditions.
The magnetically levitated centrifugal prototype incorporated
touchdown surfaces on the center spindle region and a
constraining secondary flow path. Thus, the N.I.H. values for
the repeated 4 h studies were found to be higher than desired.
Clinically approved blood pumps have demonstrated N.I.H
values of <0.04 g/100 L, and our results average N.I.H was 0.09 ±
0.02 g/100 L. The hemolytic potential of our current centrifugal
prototype design is problematic, and the hemolytic potential
must be reduced with further design improvement. Next phase
development will integrate the axial flow blood pump, and thus
the spindle region and secondary flow path will be modified to
address the complex fluid dynamics in these regions.

CONCLUSIONS
Clinically-available blood pumps and total artificial hearts for
pediatric patients continue to lag behind those developed for
adults. To address this unmet clinical need, we are developing a
hybrid-design, continuous-flow, magnetically levitated, pediatric
total artificial heart (TAH). The hybrid TAH design integrates
both an axial and centrifugal blood pump within a single,
compact housing. The centrifugal pump rotates around the
separate axial pump domain, and both impellers rotate around
a common central axis. Here, we performed computational
studies and prototyping testing for the centrifugal pump
component. The computational studies and the prototype
testing demonstrated that the centrifugal design is effective;
design requirements for the centrifugal pump were achieved.
The pressure-flow performance, axial and radial fluid forces,
scalar stresses, blood damage indices and mechanical power
consumption estimates fell within target design requirements,
except that the hemolytic potential must be reduced with further
design improvement. These data support the next phase of
development for the motor and magnetic suspension of the
centrifugal pump and integration of the axial flow blood pump
component.

Study Limitations and Future Work
This study has limitations that must be addressed in future work.
The focus of this work has been on the centrifugal pump design,
and we must improve the axial pump in future development
phases. The axial blood pump is currently under redesign to
reduce size, lower fluid forces on the levitated impeller, and
improve energy transfer. We are in the process of combining
the centrifugal prototype with the axial pump to conduct an
integrated configuration for hydraulic and hemolytic testing. We
must evaluate the integrated, full pediatric TAH design both
computationally and experimentally to evaluate the hydraulic
performance, hemolytic levels, and magnetic flux directions to
assess and address any interference between suspension systems.
Next phase hemolytic studies must include more flow rates
and rotational speeds and be conducted for a minimum of
6 h study durations. Inflow and outflow cannulae are currently
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